September 12, 2020 Comments Off on Patent delisted for Daiichi Sankyo drug BENICAR HCT Posted in: Uncategorized
Annual Drug Patent Expirations for BENICAR+HCT Benicar Hct is a drug marketed by Daiichi Sankyo and is included in one NDA. It is available from three suppliers. BENICAR HCT drug…
The post Patent delisted for Daiichi Sankyo drug BENICAR HCT appeared fi…
September 12, 2020 Comments Off on Patent delisted for Salix Pharms drug XIFAXAN Posted in: Uncategorized
Annual Drug Patent Expirations for XIFAXAN Xifaxan is a drug marketed by Salix Pharms and is included in two NDAs. It is available from two suppliers. There are twenty-six patents…
The post Patent delisted for Salix Pharms drug XIFAXAN appeared first o…
